Eurofins Scientific SEHAM:ESF0 +2.80%87 Net Margin % is 6.19% as of Dec. 2025, which is 7% below its 10-year median of 6.69. GuruFocus rates HAM:ESF0 with a GF Score™ of 87/100 and a GF Value™ of €66.73 (Fairly Valued). The stock has 6 warning signs investors should review. Among 204 Medical Diagnostics & Research companies, Eurofins Scientific SE ranks better than 67.65% on this metric.
The historical rank and industry rank for Eurofins Scientific SE's Net Margin % or its related term are showing as below:
HAM:ESF0'
s Net Margin % Range Over the Past 10 Years
Min: 4.28 Med: 6.69 Max: 11.65
Current: 6.51
HAM:ESF0's Net Margin % is ranked better than 67.65% of 204
companies
in the Medical Diagnostics & Research industry
Industry Median: -2.405
vs HAM:ESF0: 6.51
Eurofins Scientific SE (HAM:ESF0) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Eurofins Scientific SE Net Margin % Related Terms
Eurofins Scientific SE Net Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HAM:ESF0 vs TMO, DHR, IDXX: Net Margin % Comparison
For the Diagnostics & Research subindustry, Eurofins Scientific SE's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Eurofins Scientific SE Net Margin % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Eurofins Scientific SE's Net Margin % distribution charts can be found below:
* The bar in red indicates where Eurofins Scientific SE's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Eurofins Scientific SE (HAM:ESF0) has a Net Margin % of 6.19% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on Eurofins Scientific SE and its competitors. This is near median its historical median of 6.69. Over the past decade, Eurofins Scientific SE's Net Margin % has ranged from 4.28 to 11.65. According to the industry distribution chart, Eurofins Scientific SE ranks #66 out of 204 companies in the Medical Diagnostics & Research industry, placing it in the top 32.4%.
Is Eurofins Scientific SE's Net Margin % too high?
Eurofins Scientific SE's current Net Margin % of 6.19% is near median its 10-year median of 6.69. Over the past 10 years, this metric has ranged from a low of 4.28 to a high of 11.65. Based on the distribution chart, Eurofins Scientific SE ranks #66 out of 204 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Eurofins Scientific SE has a GF Score™ of 87/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Eurofins Scientific SE's Net Margin % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Eurofins Scientific SE ranks #66 out of 204 companies for Net Margin %. This puts Eurofins Scientific SE in the upper half of its industry. Historically, Eurofins Scientific SE's own Net Margin % has ranged from 4.28 to 11.65 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Diagnostics & Research company?
A good Net Margin % depends on the Medical Diagnostics & Research industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Eurofins Scientific SE and its competitors. Eurofins Scientific SE's current Net Margin % is 6.19%, which is near median its own 10-year median of 6.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eurofins Scientific SE stock overvalued right now?
Based on GuruFocus' analysis, Eurofins Scientific SE (HAM:ESF0) is currently considered Fairly Valued. The stock's GF Value™ is €66.73, compared to a current price of €66.88 — trading 0.2% above its estimated fair value. The current Net Margin % is 6.19%, which is near median its 10-year median of 6.69. Eurofins Scientific SE's overall GF Score™ is 87/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Eurofins Scientific SE (HAM:ESF0), the current Net Margin % is 6.19% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Eurofins Scientific SE (HAM:ESF0) Overvalued in 2026?
Based on GuruFocus' analysis, Eurofins Scientific SE stock appears to be overvalued.
The current stock price of €66.88 is trading 0.2% above its estimated GF Value™ of €66.73.
GuruFocus considers Eurofins Scientific SE to be Fairly Valued.
Key valuation signals for HAM:ESF0:
Net Margin %: 6.19% (near median its 10-year median of 6.69)
GF Value™: €66.73 vs. price of €66.88 (0.2% above fair value)
No single metric tells the full story. See the HAM:ESF0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Eurofins, headquartered in Luxembourg, is a decentralized network of life sciences companies that provide various analytical tests and laboratory services. These include tests to evaluate the safety, identity, composition, authenticity, purity, origin, and traceability of various biological substances and products. Eurofins operates over 950 laboratories in 61 countries. Its revenue from Europe, North America, and the rest of the world contributes approximately 50%, 40%, and 10% of total revenue, respectively. Its areas of business activity are food, feed, and environmental testing ("life"), biopharmaceutical services, diagnostic services and products, and consumer and technology products testing, which contribute approximately 40%, 30%, 20%, and 10% respectively.
87GF Score
Get the complete analysis for HAM:ESF0
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HAM:ESF0 has been successfully added to your 
